EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Treatment of an animal model of the antiphospholipid syndrome with the Ras inhibitor farnesylthiosalicilate



Treatment of an animal model of the antiphospholipid syndrome with the Ras inhibitor farnesylthiosalicilate



Journal of Autoimmunity (SUPPL ): 110




(PDF 0-2 workdays service: $29.90)

Accession: 035980926

Download citation: RISBibTeXText



Related references

Treatment of an animal model of the antiphospholipid syndrome with the Ras inhibitor farnesylthiosalycilate. Neurology 52(6 SUPPL 2): A82-A83, April 12, 1999

Activation of ERK in brain endothelial cells by thrombin and antiphospholipid antibodies and its modulation by the Ras inhibitor, farnesylthiosalicilate. Lupus 11(9): 604, 2002

An animal model for thrombosis in the antiphospholipid syndrome. Arthritis & Rheumatism 36(9 SUPPL ): S102, 1993

Autoimmune MRL-1 pr/1pr mice are an animal model for the secondary antiphospholipid syndrome. Journal of Rheumatology 17(7): 911-915, 1990

The efficacy of specific IVIG in antiphospholipid syndrome (APS): Trophoblast invasiveness and APS animal model. 2007

The NF-κB specific inhibitor DHMEQ prevents thrombus formation in a mouse model of antiphospholipid syndrome. Journal of Nephropathology 2(2): 114-121, 2014

Induction and treatment of the antiphospholipid syndrome: Lessons from animal models. European Journal of Clinical Investigation 31(8): 736-740, August, 2001

Probiotic supplementation with Lactobacillus casei (Actimel) induces a Th1 response in an animal model of antiphospholipid syndrome. Annals of the New York Academy of Sciences 1110: 661-669, 2007

The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model. International Immunology 19(7): 857-865, 2007

Induction of antiphospholipid syndrome exacerbates amyloid and plaque deposition as well as memory impairment in an animal model of Alzheimers disease. Neurology 60(5 Supplement 1): A67, March 11, 2003

Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation. International Journal of Hematology 91(5): 776-783, 2010

Antiphospholipid syndrome without antiphospholipid antibodies at the time of the thrombotic event: transient 'seronegative' antiphospholipid syndrome?. Clinical and Experimental Rheumatology 15(5): 541-544, 1997

Outcomes and treatment of obstetrical antiphospholipid syndrome in women with low antiphospholipid antibody levels. Journal of Reproductive Immunology 94(2): 222-226, 2012

Antiphospholipid antibodies and the antiphospholipid syndrome: an update on treatment and pathogenic mechanisms. Current Opinion in Hematology 13(5): 366-375, 2006